Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sydney X Lu

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Nature Reviews. Cancer|October 9, 2024
Steering research on mRNA splicing in cancer towards clinical translationOlga Anczukow, Frédéric H-T Allain, Brittany L Angarola, et al.
JAMA Oncology|July 19, 2019
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaOla Landgren, Jonathan N Hofmann, Charlene M McShane, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Age-related microbiome metabolites alter RNA splicing and chromatin accessibility in the brainMeenakshi Chakraborty, Sophia M Shi, Imani E Porter, et al.
Blood|October 8, 2008
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host diseaseSydney X Lu, Onder Alpdogan, Janine Lin, et al.
Nature Biotechnology|April 1, 2008
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursorsJohannes L Zakrzewski, David Suh, John C Markley, et al.
Nature|October 11, 2019
Spliceosomal disruption of the non-canonical BAF complex in cancerDaichi Inoue, Guo-Liang Chew, Bo Liu, et al.
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Blood|November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantationRobert R Jenq, Christopher G King, Christine Volk, et al.
The Journal of Clinical Investigation|December 4, 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseIl-Kang Na, Sydney X Lu, Nury L Yim, et al.
Nature Cancer|October 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemiaKatherine Knorr, Jahan Rahman, Caroline Erickson, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Nature Reviews. Cancer|October 9, 2024
Steering research on mRNA splicing in cancer towards clinical translationOlga Anczukow, Frédéric H-T Allain, Brittany L Angarola, et al.
JAMA Oncology|July 19, 2019
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaOla Landgren, Jonathan N Hofmann, Charlene M McShane, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Age-related microbiome metabolites alter RNA splicing and chromatin accessibility in the brainMeenakshi Chakraborty, Sophia M Shi, Imani E Porter, et al.
Blood|October 8, 2008
STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host diseaseSydney X Lu, Onder Alpdogan, Janine Lin, et al.
Nature Biotechnology|April 1, 2008
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursorsJohannes L Zakrzewski, David Suh, John C Markley, et al.
Nature|October 11, 2019
Spliceosomal disruption of the non-canonical BAF complex in cancerDaichi Inoue, Guo-Liang Chew, Bo Liu, et al.
Journal of the National Cancer Institute|May 14, 2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growthOlaf Penack, Erik Henke, David Suh, et al.
Blood|November 18, 2008
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantationRobert R Jenq, Christopher G King, Christine Volk, et al.
The Journal of Clinical Investigation|December 4, 2009
The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host diseaseIl-Kang Na, Sydney X Lu, Nury L Yim, et al.
Nature Cancer|October 23, 2023
Systematic evaluation of AML-associated antigens identifies anti-U5 SNRNP200 therapeutic antibodies for the treatment of acute myeloid leukemiaKatherine Knorr, Jahan Rahman, Caroline Erickson, et al.
Pageof 4